Exane Derivatives’s Fairmount Santrol Holdings Inc. FMSA Stock Holding History

Exane Derivatives’s Portfolio FMSA Stock Details FMSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-95,280	Closed	-$385K	–	710
2018 Q1	$385K	Buy	95,280 +20,447	+27%	+$103K	0.08%	176
2017 Q4	$392K	Sell	74,833 -22,521	-23%	-$106K	0.07%	192
2017 Q3	$465K	Buy	97,354 +9,444	+11%	+$30.6K	0.09%	142
2017 Q2	$343K	Buy	87,910 +58,857	+203%	+$305K	0.07%	163
2017 Q1	$213K	Buy	+29,053	New	+$303K	0.05%	188

Other funds holding FMSA

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Exane Derivatives's FMSA Position: Q2 2018 in Review

Exane Derivatives sold out of Fairmount Santrol Holdings Inc. (FMSA) in Q2 2018, closing a stake of 95,280 shares — an estimated $385K sold.

Exane Derivatives first reported a position in FMSA in Q1 2017 and held it in 5 quarters. The position peaked at $465K in Q3 2017. 1 fund tracked by Wall St. Rank holds FMSA as of Q2 2018.

Exane Derivatives reported no remaining Fairmount Santrol Holdings Inc. position as of Q2 2018 after selling out during the quarter.
Exane Derivatives sold 95,280 Fairmount Santrol Holdings Inc. shares in Q2 2018, an estimated $385K.
Exane Derivatives first reported a position in Fairmount Santrol Holdings Inc. in Q1 2017 and held it in 5 quarters.
Exane Derivatives's Fairmount Santrol Holdings Inc. position peaked at $465K in Q3 2017.
1 fund tracked by Wall St. Rank held Fairmount Santrol Holdings Inc. as of Q2 2018.

Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.